SCOPUS 정보 검색 플랫폼

Journal of Japanese Society of Gastroenterology

Volumn 109, Issue 5, 2012, Pages 774-780

Clinical efficacy of adalimumab for a postoperative marginal ulcer in gastrointestinal Behçet disease

(9) Shimizu, Yui b Takeda, Tsuyoshi b Matsumoto, Ryusuke b Yoshida, Kou b Nakajima, Junta b Atarashi, Tomofumi b Yanagisawa, Hideyuki a Kikuchi, Keisuke a Kikuchi, Hideaki a

a Obihiro Kosei General Hospital (Japan)

b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; INFLIXIMAB;

ADULT; ARTHRALGIA; ARTICLE; BEHCET DISEASE; CASE REPORT; CLINICAL EFFECTIVENESS; CLINICAL EXAMINATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FEMALE; GASTROINTESTINAL BEHCET DISEASE; GASTROINTESTINAL DISEASE; HUMAN; HYPERSENSITIVITY; JEJUNUM ULCER; POSTOPERATIVE PERIOD; STEROID THERAPY; TOTAL STOMACH RESECTION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84861745748 PISSN: 04466586 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (10)

References (11)

1
- 85171938671
- Japanese source

2
- 85171936348
- Japanese source

3
- 54349092816
- Efficacy of Infliximab for induction and maintenance of remission in intestinal Behçet's disease
- Naganuma M, Sakuraba A, Hisamatsu T, et al : Efficacy of Infliximab for induction and maintenance of remission in intestinal Behçet's disease. Inflamm Bowel Dis 14; 1259-1264 : 2008
- (2008) Inflamm Bowel Dis , vol.14 , pp. 1259-1264
- Naganuma, M.¹ Sakuraba, A.² Hisamatsu, T.³

4
- 34248588786
- Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor alpha monoclonal antibody (Infliximab)
- Lee JH, Kim TN, Choi ST, et al : Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor alpha monoclonal antibody (Infliximab). Korean J Intern Med 22; 24-27 : 2007
- (2007) Korean J Intern Med , vol.22 , pp. 24-27
- Lee, J.H.¹ Kim, T.N.² Choi, S.T.³

5
- 85171945928
- Japanese source

6
- 79960139513
- Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease
- Iwata S, Saito K, Yamaoka K, et al : Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease. Mod Rheumatol 21; 184-191 : 2011
- (2011) Mod Rheumatol , vol.21 , pp. 184-191
- Iwata, S.¹ Saito, K.² Yamaoka, K.³

7
- 34347212190
- Anti-TNF therapy in the management of Behçet's disease-review and basis for recommendations
- Sfikakis PP, Markomichelakis N, Alpsoy E, et al : Anti-TNF therapy in the management of Behçet's disease-review and basis for recommendations. Rheumatology 46; 736-741 : 2007
- (2007) Rheumatology , vol.46 , pp. 736-741
- Sfikakis, P.P.¹ Markomichelakis, N.² Alpsoy, E.³

8
- 85171906553
- Japanese source

9
- 79954441287
- Successful switching to adalimumab in an infliximab-allergic patient with severe Behçet disease-related uveitis
- Takase K, Ohno S, Ideguchi H, et al : Successful switching to adalimumab in an infliximab-allergic patient with severe Behçet disease-related uveitis. Rheumatol Int 31; 243-245 : 2011
- (2011) Rheumatol Int , vol.31 , pp. 243-245
- Takase, K.¹ Ohno, S.² Ideguchi, H.³

10
- 34147211262
- Adalimumab: A new modality for Behçet's disease?
- van Laar JA, Missotten T, va Daele PL, et al : Adalimumab : a new modality for Behçet's disease? Ann Rheum Dis 66; 565-566 : 2007
- (2007) Ann Rheum Dis , vol.66 , pp. 565-566
- Van Laar, J.A.¹ Missotten, T.² Va Daele, P.L.³

11
- 72549105127
- Intestinal Behçet's disease: Maintenance of remission with adalimumab monotherapy
- Ariyachaipanich A, Berkelhammer C, Nicola H : Intestinal Behçet's disease : maintenance of remission with adalimumab monotherapy. Inflamm Bowel Dis 15; 1769-1771 : 2009
- (2009) Inflamm Bowel Dis , vol.15 , pp. 1769-1771
- Ariyachaipanich, A.¹ Berkelhammer, C.² Nicola, H.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.